Category: ADHD/ADD

ADHD is the most common emotional, cognitive and behavioral disorder treated in children1, and according to the National Institute of Mental Health (NIMH), between 30 percent and 70 percent of children with ADHD continue to exhibit symptoms in the adult years 2.

Share and Enjoy:
These icons link to social bookmarking sites where readers can share and […]

Researchers at the University of Pittsburgh and the Western Psychiatric Institute and Clinic of UPMC have received $3 million from the National Institute of Mental Health to conduct a national study of the treatment of attention deficit hyperactivity disorder (ADHD) in children with autism spectrum disorders.

Share and Enjoy:
These icons link to social bookmarking sites where […]

Stimulant medications such as Ritalin have been prescribed for decades to treat attention deficit hyperactivity disorder (ADHD), and their popularity as “cognition enhancers” has recently surged among the healthy, as well.What’s now starting to catch up is knowledge of what these drugs actually do in the brain.

Share and Enjoy:
These icons link to social bookmarking sites […]

Concept Media, a leading producer and distributor of healthcare education media, has just released ADHD: Attention Deficit/Hyperactivity Disorder, Autism Spectrum Disorders, and Mental Retardation in DVD and CD-ROM formats. These new scenario-based series have a multidisciplinary focus that features medicine, nursing, education, and human development.

Share and Enjoy:
These icons link to social bookmarking sites where readers […]

An ADHD-associated version of the human gene DRD4 is linked to better health among nomadic tribesmen, but may cause malnourishment in their settled cousins, according to new research by a team directed by an anthropologist at the University of Wisconsin-Milwaukee (UWM).

Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover […]

Sciele Pharma, Inc. (NASDAQ: SCRX), a specialty pharmaceutical company, announced that Addrenex Pharmaceuticals has completed patient enrollment of its first Phase III clinical trial in the U.S. for Clonicel to treat attention deficit and hyperactivity disorder (ADHD) in children. Addrenex is also continuing to enroll patients in an additional Phase III trial using Clonicel in […]

PsychoGenics Inc. announced positive data from its randomized, placebo controlled, multicenter, Phase IIa trial of eltoprazine, the company’s lead partial 5-HT1A - 5-HT1B receptor agonist, in adult patients with Attention Deficit/ Hyperactivity Disorder (ADHD).

Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.

Food may not be the major cause of hyperactivity in children. Genetics, brain function and parental actions such as smoking may be just as important.A review of scientific evidence found only a minority of children were actually affected by what they eat. A combination of food, genetics and environmental toxins are more likely to be […]

The American Heart Association released on April 21, 2008, a statement about cardiovascular evaluation and monitoring of children receiving drugs for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). As a result of language in the news release and the statement as published, there have been conflicting interpretations of the recommendations regarding the use of […]

Adults with attention deficit hyperactivity disorder (ADHD) treated in an investigational study with OROS® methylphenidate tablets experienced significantly greater improvements in their ADHD symptoms compared to patients taking placebo, according to findings from a trial published in Biological Psychiatry.

Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web […]